Staphylococcus aureus immune globulin - Inhibitex
Alternative Names: SA-IGIVLatest Information Update: 28 Jul 2004
At a glance
- Originator Inhibitex
- Class Antibacterials; Immunoglobulins; Polyclonal antibodies
- Mechanism of Action Cell adhesion molecule inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Staphylococcal infections
Most Recent Events
- 28 Jul 2004 Discontinued - Phase-II for Staphylococcal infections in USA (unspecified route)
- 18 Oct 2002 No development reported - Phase-II for Staphylococcal infections in USA (unspecified route)
- 13 Apr 2000 Phase-II clinical trials for Staphylococcal infections in USA (Unknown route)